Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Abiraterone Acetate × Prednisolone × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lymphoma 37 Prostatic Neoplasms 28 Precursor Cell Lymphoblastic Leukemia-Lymphoma 27 Lymphoma, Large B-Cell, Diffuse 25 Leukemia 14 Lymphoma, Follicular 13 Lymphoma, Non-Hodgkin 11 Hodgkin Disease 10 Burkitt Lymphoma 8 Neoplasm Metastasis 7 Leukemia, Biphenotypic, Acute 6 Recurrence 5 Lymphoma, B-Cell 5 Hemangioma 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Ovarian Neoplasms 4 Lymphoma, Large-Cell, Anaplastic 4 Immunoblastic Lymphadenopathy 4 Neoplasms 3 Multiple Myeloma 3 Lymphoma, Large-Cell, Immunoblastic 3 Dendritic Cell Sarcoma, Interdigitating 3 Breast Neoplasms 3 Neurotoxicity Syndromes 2 Neoplasm, Residual 2 Myasthenia Gravis 2 Metastatic Castration-resistant Prostate Cancer 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell 2 Lymphoma, Mantle-Cell 2

Interventions

Prednisolone 1 BID protein, human 1 Androgen Antagonists 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06768255 2025-01-10

mCRPC

Fudan University

Phase 3 Not yet recruiting

Abiraterone Acetate

Data powered by HemOnc (CC BY 4.0) Colophon ⚡